Cis-(+)-8-OH-1-CH3-DPAT, (+)ALK-3, a novel stereoselective pharmacological probe for characterizing 5-HT release-controlling 5-HT1A autoreceptors

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  1990-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF00169724PMID 1692973
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dopamine receptor agonists: Intrinsic activity vs. state of receptor

  2005cited by this paper
• Sub-chronic administration of (−)-3-PPP and central dopamine receptor sensitivity changes

  2005cited by this paper
• Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites

  2004cited by this paper
• Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.

  1990cited by this paper
• Mixed agonist/antagonist properties of NAN-190 at 5-HT1A receptors: behavioural and in vivo brain microdialysis studies.

  1990cited by this paper
• Pharmacological characterization of 8‐OH‐DPAT‐induced inhibition of rat hippocampal 5‐HT release in vivo as measured by microdialysis

  1989cited by this paper
• Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain.

  1989cited by this paper
• 5‐HT1 agonists reduce 5‐hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis

  1989cited by this paper
• Electrophysiological assessment of putative antagonists of 5-hydroxytryptamine receptors: a single-cell study in the rat dorsal raphe nucleus.

  1989cited by this paper
• Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.

  1989cited by this paper
• In Vivo Measurement of Extracellular 5‐Hydroxytryptamine in Hippocampus of the Anaesthetized Rat Using Microdialysis: Changes in Relation to 5‐Hydroxytryptaminergic Neuronal Activity

  1989cited by this paper
• Functional correlates of serotonin 5-HT1 recognition sites.

  1988cited by this paper
• Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons.

  1988cited by this paper
• Endogenous Release of Neuronal Serotonin and 5‐Hydroxyindoleacetic Acid in the Caudate‐Putamen of the Rat as Revealed by Intracerebral Dialysis Coupled to High‐Performance Liquid Chromatography with Fluorimetric Detection

  1988cited by this paper
• Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor.

  1988cited by this paper
• The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo.

  1988cited by this paper
• The 5-HT1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo

  1988cited by this paper
• Structural factors of importance for 5-hydroxytryptaminergic activity. Conformational preferences and electrostatic potentials of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and some related agents.

  1988cited by this paper
• Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.

  1988cited by this paper
• Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.

  1988cited by this paper
• Electrophysiological evidence that spiperone is an antagonist of 5-HT1A receptors in the dorsal raphe nucleus.

  1988cited by this paper
• (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.

  1987cited by this paper
• Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonists

  1987cited by this paper
• 5-HT1A receptor-related anxiolytics

  1987cited by this paper
• Effects of the C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on central 5-hydroxytryptamine receptors.

  1987cited by this paper
• Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug.

  1986cited by this paper
• Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome.

  1986cited by this paper
• Serotonin neurochemistry revisited: A new look at some old axioms.

  1986cited by this paper
• Evidence for the localization of 5HT1A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain.

  1985cited by this paper
• Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype.

  1985cited by this paper
• 8-Hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H] 5-HT recognition site

  1984cited by this paper
• The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

  1984cited by this paper
• Electrophysiologically-identified serotonin receptors in the rat CNS. Effect of antidepressant treatment.

  1984cited by this paper
• 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists.

  1984cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site.

  1983cited by this paper
• 8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity

  1982cited by this paper
• Buspirone: effects on central monoaminergic transmission--possible relevance to animal experimental and clinical findings.

  1982cited by this paper
• Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals.

  1981cited by this paper
• 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist.

  1981cited by this paper
• An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat

  1978cited by this paper
• Feedback regulation of central monoaminergic neurons: evidence from single cell recording studies.

  1978cited by this paper

• Simultaneous comparison of cerebral dialysis and push-pull perfusion in the brain of rats: a critical review.

  1998cites this paper
• (R)-11-hydroxy- and (R)-11-hydroxy-10-methylaporphine: synthesis, pharmacology, and modeling of D2A and 5-HT1A receptor interactions.

  1995cites this paper
• Derivatives of cis-2-amino-8-hydroxy-1-methyltetralin: mixed 5-HT1A-receptor agonists and dopamine D2-receptor antagonists.

  1995cites this paper
• Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat.

  1994cites this paper
• Iodinated 2-aminotetralins and 3-amino-1-benzopyrans: ligands for dopamine D2 and D3 receptors.

  1994cites this paper
• Synthesis of (+)-(R)- and (-)-(S)-5-hydroxy-2-methyl-2-dipropylaminotetralin: effects on rat hippocampal output of 5-HT, 5-HIAA, and DOPAC as determined by in vivo microdialysis.

  1993cites this paper
• The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release.

  1993cites this paper
• Anxiolytic effects of the 5-HT1A receptor agonist ipsapirone in the rat: neurobiological correlates.

  1993cites this paper
• α2-Adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo

  1992cites this paper
• The novel 5-HT1A receptor antagonist (S)-UH-301 prevents (R)-8-OH-DPAT-induced decrease in interstitial concentrations of serotonin in the rat hippocampus.

  1992cites this paper
• (-)-Penbutolol as a blocker of central 5-HT1A receptor-mediated responses.

  1992cites this paper
• Differences in the In Vitro and In Vivo 5‐Hydroxytryptamine Extraction Performance Among Three Common Microdialysis Membranes

  1992cites this paper
• A 3-D model for 5-HT1A-receptor agonists based on stereoselective methyl-substituted and conformationally restricted analogues of 8-hydroxy-2-(dipropylamino)tetralin.

  1991cites this paper
• Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor.

  1990cites this paper
• Effects of MDL 73005EF on central pre- and postsynaptic 5-HT1A receptor function in the rat in vivo.

  1990cites this paper